To view this email as a web page, click here.

 
Budding technology could be an OCT analysis game-changer
Tools for higher-order OCT assessment enable evaluation of features of interest, such as targeted retinal layers or fluid compartments, and may allow for unique characterization of disease phenotypes and treatment response.
Find out
ADVERTISEMENT
 
Weigh risk, benefits of cataract surgery for your patients
Doug Katsev, MD, takes a look at two key factors for patients suffering from vision loss who are also considering undergoing cataract surgery, including the association with age-related macular degeneration (AMD).
Learn more
 
Teleglaucoma lets patients be more engaged in care
New technology for taking the evaluation, diagnosis, and management of glaucoma out of the clinic and directly to the patient is influencing not only community outreach efforts but the feasibility of using teleglaucoma tools in the home.
Read on
 
ADVERTISEMENT
See who is attending OIS@AAO
View the impressive list of delegates already signed up to attend OIS@AAO on October 10th in San Francisco. If you aren’t already on the list, be sure to register: https://ois.net/ois-aao-2019/oisaao-2019-attendees/
 
RELATED ARTICLES
 
Safety key for intracamerally injected mydriatic agents in cataract surgery
Understand the expanding role of IPL in dry eye disease
These 3 things are part of a cataract surgeon’s signature
10 effective habits of a cataract surgeon
Quieting the neuropathic components of ocular pain
Pearls to manage cataract surgery on hypotonous eyes
Pushing the boundaries with monofocal toric IOL
 
ADVERTISEMENT
Unleash the Power of your Optical.
We’ll help you reach the untapped potential within your dispensary. Imagine if your optical performed as well as your practice? Now it can. Vision, the largest optical dispensary management and consulting firm in the country can help! www.visassoc.com. AAO Booth #5048
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.